Autopsy report · NCT04531592

Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients

“Study terminated by the Sponsor”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Westat

Sponsor type

University, hospital or other

Conditions

Acute Kidney Injury; Ischemia Reperfusion Injury

Interventions

Valproic acid; Isotonic saline solution

Participants

0

Sites

4

Countries

United States

Trials that died the same way

• Visual Function Tests in Age-related Macular Degeneration
  “Study terminated by Sponsor” (99% match in meaning)
• Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
  “Study terminated at Sponsor's request.” (96% match in meaning)
• Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera
  “The study was terminated by the sponsor” (96% match in meaning)
• Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria
  “Sponsor terminated study” (96% match in meaning)
• Comprehensive Medication Monitoring on Heart Failure Patient Outcomes
  “Study terminated by sponsor for commercial reasons” (95% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.